Yifu Ma
Suzhou, 215123, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Citraconate preserves T cell stemness and antitumor immunity.
Journal: Science immunology
Published: May 01, 2026
Clinical Considerations of Splenic Dose Constraints to Mitigate Radiation-Induced Lymphopenia.
Journal: Cancer medicine
Published: June 07, 2025
Phase I/II Clinical Study of PRaG Regimen Combined With Intraperitoneal Infusion of PD-1 Inhibitor for Advanced Refractory Solid Tumors With Cancerous Ascites (PRaG4.0P Study).
Journal: Technology in cancer research & treatment
Published: July 25, 2024
The relationship between splenic dose and radiation-induced lymphopenia.
Journal: Journal of radiation research
Published: January 18, 2024
Cystine deprivation triggers CD36-mediated ferroptosis and dysfunction of tumor infiltrating CD8+ T cells.
Journal: Cell death & disease
Published: November 01, 2023
PD-1 Inhibitor Combined With Radiotherapy and GM-CSF (PRaG) in Patients With Metastatic Solid Tumors: An Open-Label Phase II Study.
Journal: Frontiers in immunology
Published: May 24, 2022
PRaG Therapy of Refractory Metastatic Gastric Cancer: A Case Report.
Journal: Frontiers in immunology
Published: April 23, 2022
Optimizing the Treatment Schedule of Radiotherapy Combined With Anti-PD-1/PD-L1 Immunotherapy in Metastatic Cancers.
Journal: Frontiers in oncology
Published: December 07, 2020
The prognostic value of the lymph node ratio for local advanced gastric cancer patients with intensity-modulated radiation therapy and concurrent chemotherapy after radical gastrectomy in China.
Journal: Radiation oncology (London, England)
Published: September 08, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026